tapebrief
WRB · Q1 2026

WRB · Q2 2026 Earnings

Cautious

W. R. Berkley Corporation

Reported July 20, 2026

30-second summary

Berkley printed Q2 2026 with a 90.0% combined ratio, 20.5% operating ROE, and net premiums earned of $3.19B (+2.9% YoY), with operating EPS of $1.27 versus $1.05 prior-year. The signal worth flagging: last quarter's explicit "take our foot off the rate pedal" pivot did not translate into faster written premium — Insurance NPW grew just +3.7% versus the +5% threshold flagged as the test of whether the pivot was action or rhetoric, and Reinsurance & Monoline Excess NPW deteriorated to -9.3%, landing inside (not better than) the -5% to -10% "step-change" scenario. Combined with net investment income of $418.7M (clearing the $380M watch threshold decisively) and a 20.5% operating ROE, the quarter reads as underwriting-and-investing discipline still doing the work while the growth reacceleration story slips another quarter.

Headline numbers

EPS

Q2 FY2026

$1.27

+17.6% vs est.

Revenue

Q2 FY2026

$3.19B

+2.9% YoY

-0.3% vs est.

Operating margin

Q2 FY2026

13.4%

Key financials

Q2 FY2026
MetricQ2 FY2026Q2 FY2025YoYQ1 FY2026QoQ
Revenue$3.19B—+2.9%$3.69B-13.6%
EPS$1.27$1.05+21.0%$1.30-2.3%
Operating margin13.4%——13.9%-52bps

Guidance

Strong Q2 FY2026 earnings beat with 17.6% EPS surprise and 20.5% operating ROE; no quantitative forward guidance disclosed for Q3 or full FY2026, relying instead on prior qualitative statements regarding capital returns and risk-adjusted positioning.

Guidance is issued for the full year only, refreshed each quarter. Prior and new below are the same FY updated this quarter.

Actuals vs prior guidance

MetricPeriodPrior guideActualΔResult
EPS (Non-GAAP)Q2 FY2026—1.27+17.6% above consensus estimate of $1.08Beat
RevenueQ2 FY2026—3.19-0.3% vs consensus estimate of $3.20B (essentially in-line)Met
Combined RatioQ2 FY2026—90.0%Strong underwriting discipline; Current Accident Year ex-CAT ratio 88.1%Met
Operating Return on EquityQ2 FY2026—20.5%Exceeds stated 15% target ROE guidanceBeat

Segment performance

Q2 FY2026
SegmentQ2 FY2026Q2 FY2025YoY
Insurance$2.826B$2.729B+3.6%
Reinsurance & Monoline Excess$0.361B$0.369B-2.2%

Capital & returns

Q2 FY2026
SegmentQ2 FY2026Q2 FY2025YoY
Return on Equity18.6%——
Operating Return on Equity20.5%20.0%—
Total Capital Returned to Shareholders$334.1M——

Other KPIs

Q2 FY2026
SegmentQ2 FY2026Q2 FY2025YoY
Gross Premiums Written$4.1B——
Net Premiums Written$3.43B$3.351 billion—
Combined Ratio90.0%91.6%—
Current Accident Year Combined Ratio (ex-CAT)88.1%——
Net Investment Income$418.7M$379.3 million—

Management tone

No transcript was available for this quarter; tone analysis is based on the press release language and qualitative statements disclosed in the earnings release only.

Narrative arc: Q3 cautious-margin-defense → Q4 confident-investment-cycle-pivot → Q1 rate-to-growth-rebalancing → Q2 quiet-return-to-qualitative-defense.

The written framing this quarter is materially less specific than either Q4 2025 or Q1 2026. For two consecutive quarters, management gave investors quantifiable anchors — the reaffirmed 15% ROE floor, the sub-30% expense ratio, the ~23% tax rate, and Q1's explicit rate-vs-growth rebalancing thesis. This quarter's press release reduces the guidance surface to four qualitative statements: confidence in generating "excellent returns," attractive opportunities in "select liability lines," "well positioned to create long-term shareholder value," and "unwavering focus on risk-adjusted returns." None of the prior quantitative anchors are restated.

The "select liability lines" phrasing is worth reading against Q1's more expansive "push harder on growth in particular lines where we see the margin is particularly attractive." Q1 was a green-light framing for selective acceleration; Q2's "select liability lines" is narrower and defensive — the word "attractive" pairs with "opportunities" rather than with the willingness to trade rate for volume. Combined with the +3.7% Insurance NPW print, the language shift is directionally consistent with a rate-to-growth pivot that is being executed with more restraint than Q1 implied.

The capital return framing held its ground — "significant amounts of capital" language matches the Q1 formulation — but the $334.1M return itself included a $185.5M special dividend, and there is no restatement of the "for the foreseeable future" timeframe qualifier that Q1 used. Stripping the special, underlying capital return ran at roughly $149M — a meaningful step-down from Q1's cadence, and consistent with a posture that leans on lumpy specials rather than a sustained elevated buyback pace.

Answers to last quarter's watch list

Does the rate-vs-growth pivot translate to written premium in Q2? Insurance NPW grew +3.7%, below the +5% threshold flagged. This is directionally better than Q1's +3.2% but not enough to validate the pivot as operational — two quarters at ~+3% after management explicitly committed to leaning into growth in select lines is meaningful. Either the 60-90-day quoting lag is longer than telegraphed, or the "select" pockets are narrower than Q1's rhetoric implied.
Resolved negatively
Reinsurance & Monoline Excess NPW trajectory after the -10.1% Q1 shock. Reinsurance & Monoline Excess NPW printed -9.3%, landing inside the -5% to -10% "step-change" scenario and comparable in magnitude to Q1's shock rather than stabilizing off it. NPE at -2.2% still lags the written-side decline. The "buyer not seller" positioning is compounding, not cycling out.
Resolved negatively
Expense ratio progression as tech/AI spend ramps. Consolidated expense ratio printed 28.5%, flat YoY and still within the "comfortably below 30%" prior framing — though that specific commitment was not restated in this quarter's language. Insurance segment expense ratio was 28.3% (flat YoY); Reinsurance & Monoline Excess was 30.1% (up 40bps YoY, reflecting the shrinking earned base). Status: Resolved neutrally
Net investment income dollar level and yield commentary. NII printed a record $418.7M — clearing the $380M Q1 watch threshold by nearly 10% and materially above Q4 2025's $338.2M. Management cited fixed-maturity NII up 11.9%, reflecting growth in invested assets and higher portfolio yield, with reinvestment rates continuing to exceed the annual book yield against a 3.2-year duration. This decisively reverses the two-quarter sequential decline flagged two quarters ago.
Resolved positively
Capital return mix in Q2. Capital returned to shareholders was $334.1M, composed of $185.5M special dividends, $111.5M share repurchases, and $37.1M regular dividends. The special-dividend share means underlying run-rate return was roughly $149M — a step-down from Q1's cadence. The "significant amounts of capital" language holds, but the reliance on a special to reach the headline figure suggests the Q1 elevated pace does not represent the new sustainable cadence.
Continue monitoring

What to watch into next quarter

Whether Insurance NPW clears +5% in Q3, or whether +3–4% is the new operating zone. Two quarters at ~+3% following an explicit rate-to-growth pivot is a pattern; a third would confirm the pivot was rhetorical. Watch specifically whether Rob Berkley restates or retires the "take our foot off the rate pedal" framing on the Q3 call.

Restoration of quantitative guidance anchors in the Q3 disclosure. Watch whether the 15% ROE floor, "comfortably below 30%" expense ratio, and ~23% effective tax rate reappear in the press release language or are confined to the transcript. Sustained absence would confirm a deliberate narrowing of guidance precision.

Net investment income durability at the $418.7M level. The Q2 print is materially above the prior four-quarter run and reverses the sequential decline decisively. Watch whether Q3 NII sustains above $400M (confirming a step-change) or reverts to the $340–380M band (marking Q2 as a favorable-timing outlier).

Reinsurance & Monoline Excess NPW trajectory continuation. With Q2 NPW at -9.3%, watch whether Q3 arrests the decline or continues at high-single-digit-negative or worse. The written-side contraction has not yet fully flowed to earned premium, so NPE weakness will likely widen in H2 regardless of the Q3 written print.

Current accident year ex-CAT combined ratio direction. Two consecutive quarters of 20bps improvement (Q1 88.3% → Q2 88.1%) suggests the underlying underwriting margin is still widening. Watch whether Q3 sustains below 88.5% — that would validate rate adequacy is still ahead of loss trend despite the softening market management flagged at Q1.

Sources

  1. W. R. Berkley Corporation Q2 2026 press release (8-K Exhibit 99.1), filed 2026-07-20: https://www.sec.gov/Archives/edgar/data/11544/000001154426000033/wrb63020268-kex991.htm
  2. Prior quarter briefs (Q2 2025 through Q1 2026) for tone and trajectory context.

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.